Supernus Pharmaceuticals (SUPN) Other Accumulated Expenses (2011 - 2026)
Supernus Pharmaceuticals' Other Accumulated Expenses came in at $198.84 million for Q2 2026, up 9.9% from $180.92 million a year earlier and up 4.8% from the prior quarter.
Supernus Pharmaceuticals (SUPN) Other Accumulated Expenses (2011 - 2026) Analysis & Trends
At the end of FY2025, Supernus Pharmaceuticals' Other Accumulated Expenses was $161.1 million, down 4.5% from FY2024.
- Other Accumulated Expenses carries a five-year compound annual growth rate of 5.0% (FY2020 to FY2025).
- Going back by year, Other Accumulated Expenses was $168.71 million in FY2024 (+9.4%), $154.27 million in FY2023 (+1.7%), $151.67 million in FY2022 (+14.3%) and $132.72 million in FY2021 (+5.2%).
- The Q2 2026 figure represents the highest quarterly Other Accumulated Expenses in data going back to Q4 2011.
- Year-over-year, Other Accumulated Expenses increased in seven of the last eight quarters, with growth averaging 5.6%.
- The fastest year-over-year change in Other Accumulated Expenses over five years came in Q3 2022 (growth of 20.0%), and the weakest in Q2 2022 (a decline of 16.0%).
- Business Quant data shows SUPN's Other Accumulated Expenses at $189.72 million (Q1 2026), $161.1 million (Q4 2025) and $184.46 million (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Supernus Pharmaceuticals | 2.47 Bn | 1.12 Bn | 185.39 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 198.84 Mn |
| Mar 31, 2026 | 189.72 Mn |
| Dec 31, 2025 | 161.10 Mn |
| Sep 30, 2025 | 184.46 Mn |
| Jun 30, 2025 | 180.92 Mn |
| Mar 31, 2025 | 170.13 Mn |
| Dec 31, 2024 | 168.71 Mn |
| Sep 30, 2024 | 169.12 Mn |
| Jun 30, 2024 | 175.12 Mn |
| Mar 31, 2024 | 167.23 Mn |
| Dec 31, 2023 | 154.27 Mn |
| Sep 30, 2023 | 162.47 Mn |
| Jun 30, 2023 | 148.83 Mn |
| Mar 31, 2023 | 147.85 Mn |
| Dec 31, 2022 | 151.67 Mn |
| Sep 30, 2022 | 158.47 Mn |
| Jun 30, 2022 | 145.76 Mn |
| Mar 31, 2022 | 140.18 Mn |
| Dec 31, 2021 | 132.72 Mn |
| Sep 30, 2021 | 132.05 Mn |
Supernus Pharmaceuticals Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=SUPN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "SUPN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=SUPN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();